Eric Débiton
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
- Organic Chemistry top 5%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Click Chemistry and Applications
Papers in
-
- Bioactive Compounds and Antitumor Agents 6
- Co-authors
- Chantal Barthomeuf (11 shared papers)Jean‐Claude Madelmont (9 shared papers)J Legault (2 shared papers)Walter M. A. Westerink (2 shared papers)Willem G.E.J. Schoonen (2 shared papers)Jeroen A.D.M. de Roos (2 shared papers)Pascale Moreau (9 shared papers)Fabrice Anizon (8 shared papers)
In The Last Decade
Eric Débiton
52 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 114
- Toxicology 93
- Organic Chemistry 570
- Pharmacology 143
- Pharmacology 219
- Molecular Biology 842
Countries citing papers authored by Eric Débiton
This map shows the geographic impact of Eric Débiton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Débiton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Débiton more than expected).
Fields of papers citing papers by Eric Débiton
This network shows the impact of papers produced by Eric Débiton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Débiton. The network helps show where Eric Débiton may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Débiton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 178 | |
| 2 | 2003 | 110 | |
| 3 | 2002 | 108 | |
| 4 | 2005 | 106 | |
| 5 | 2005 | 102 | |
| 6 | 2011 | 98 | |
| 7 | 2007 | 96 | |
| 8 | 1996 | 79 | |
| 9 | 2007 | 78 | |
| 10 | 2009 | 70 | |
| 11 | 2002 | 69 | |
| 12 | 2013 | 66 | |
| 13 | 2005 | 58 | |
| 14 | Conjugated linoleic acid isomers and their conjugated derivatives inhibit growth of human cancer cell lines. | 2006 | 52 |
| 15 | 2006 | 52 | |
| 16 | 2008 | 50 | |
| 17 | 2006 | 40 | |
| 18 | 2008 | 39 | |
| 19 | 2008 | 37 | |
| 20 | 2001 | 34 |
About Eric Débiton
Eric Débiton is a scholar working on Toxicology, Cancer Research, Molecular Biology, Organic Chemistry and Biotechnology, having authored 53 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (9 papers), Bioactive Compounds and Antitumor Agents (6 papers), Click Chemistry and Applications (5 papers), Synthesis and biological activity (4 papers), Cancer Research and Treatments (3 papers), Synthesis and bioactivity of alkaloids (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Estrogen and related hormone effects (3 papers). The work is most often cited by research in Toxicology (93 citations), Organic Chemistry (570 citations), Pharmacology (143 citations), Pharmacology (219 citations) and Molecular Biology (842 citations). Eric Débiton has collaborated with scholars based in France, Canada and Morocco. Frequent co-authors include Chantal Barthomeuf, Jean‐Claude Madelmont, J Legault, Walter M. A. Westerink, Willem G.E.J. Schoonen, Jeroen A.D.M. de Roos, Pascale Moreau, Fabrice Anizon, André Pichette and Michelle Prudhomme. Their work appears in journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Planta Medica, Anti-Cancer Drugs and Melanoma Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.